Details for Patent: 7,153,856
✉ Email this page to a colleague
Summary for Patent: 7,153,856
Title: | Cyclic protein tyrosine kinase inhibitors |
Abstract: | Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders. |
Inventor(s): | Barrish; Joel C. (Richboro, PA), Wityak; John (Carlsbad, CA), Das; Jagabandhu (Mercerville, NJ), Chen; Ping (Belle Mead, NJ), Norris; Derek J. (Pennington, NJ), Schieven; Gary (Lawrenceville, NJ) |
Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
Application Number: | 11/138,942 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,153,856
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,153,856
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 1169038 | ⤷ Sign Up | 13C0003 | France | ⤷ Sign Up |
European Patent Office | 1169038 | ⤷ Sign Up | C300567 | Netherlands | ⤷ Sign Up |
European Patent Office | 1169038 | ⤷ Sign Up | C01169038/01 | Switzerland | ⤷ Sign Up |
European Patent Office | 1169038 | ⤷ Sign Up | CA 2013 00006 | Denmark | ⤷ Sign Up |
European Patent Office | 1169038 | ⤷ Sign Up | 92146 | Luxembourg | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |